EUS-FNA versus Biliary Brushings and Assessment of Simultaneous Performance in Jaundiced Patients with Suspected Malignant Obstruction

  • Kofi Oppong Department of Gastroenterology, Freeman Hospital. Newcastle upon Tyne, United Kingdom
  • Dan Raine Department of Gastroenterology, Freeman Hospital. Newcastle upon Tyne, United Kingdom
  • Manu Nayar Department of Gastroenterology, Freeman Hospital. Newcastle upon Tyne, United Kingdom
  • Viney Wadehra Department of Cytopathology, Royal Victoria Infirmary. Newcastle upon Tyne, United Kingdom
  • Subramaniam Ramakrishnan Department of Gastroenterology, Warrington Hospital. Warrington, United Kingdom
  • Richard M Charnley Department of HPB Surgery, Freeman Hospital. Newcastle upon Tyne, United Kingdom
Keywords: Carcinoma, Pancreatic Ductal, Cholangiopancreatography, Endoscopic Retrograde, Endosonography

Abstract

Context Individuals with suspected malignant biliary obstruction commonly undergo ERCP for drainage and tissue sampling via biliary brushings. EUS with EUS-FNA facilitates staging and potentially more accurate tissue sampling. Objective The aim is to compare the diagnostic performance of EUS-FNA and ERCP with biliary brushings (ERCP-BB) in the diagnosis of pancreatobiliary carcinoma and the utility of combining the two procedures under conscious sedation. Design Retrospective analysis of a prospectively maintained database. Patients Thirty-seven patients with suspected malignant obstructive jaundice underwent 39 paired procedures, either combined (n=22) or within a few days (n=17). Results Using strict cytological criteria the sensitivity of EUS-FNA in the diagnosis of malignancy was 52.9% (95% CI: 35.1-70.2%) versus 29.4% (95% CI: 15.1-47.5%) for ERCP-BB. Combining the two tests improved sensitivity to 64.7% (95% CI: 46.5-80.3%) which was significantly better than ERCP-BB alone (P=0.001) but not EUS-FNA alone (P=0.125). When both procedures were performed under the same conscious sedation, there was a significant difference (P=0.031) between the sensitivity of EUS-FNA (52.6%; 95% CI: 28.9-75.6%) and that of ERCP-BB (21.1%; 95% CI: 6.1-45.6%). When both procedures were performed together the mean±SD in-room time was 79±14 min (range: 45-105 min). Two of the patients (9.1%) had a complication. Conclusions In patients undergoing EUS-FNA and ERCP-BB under the same sedation, EUS-FNA was significantly more sensitive in diagnosing malignancy. Combining the results of both tests improved diagnostic accuracy. Combining therapeutic ERCP and EUS-FNA under the same conscious sedation is feasible, with a complication rate similar to that of ERCP alone.

Image: Freeman Hospital. Newcastle upon Tyne, United Kingdom.

Downloads

Download data is not yet available.

References

Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 2008; 143:75-83. [PMID 18209156]

Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 2000; 7:55-66. [PMID 10674450]

Mansfield SD, Barakat O, Charnley RM, Jaques BC, O'Suilleabhain CB, Atherton PJ, Manas D. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 2005; 11:7625-30. [PMID 16437689]

Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc 2006; 63:71-7. [PMID 16377319]

de Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 2002; 56:720-30. [PMID 12397282]

Mansfield SD, Scott J, Oppong K, Richardson DL, Sen G, Jaques BC, et al. Comparison of multislice computed tomography and endoscopic ultrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy. Br J Surg 2008; 95:1512-20. [PMID 18942059]

Kala Z, Valek V, Hlavsa J, Hana K, Vanova A. The role of CT and endoscopic ultrasound in pre-operative staging of pancreatic cancer. Eur J Radiol 2007; 62:166-9. [PMID 17344007]

Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006; 4:717-25. [PMID 16675307]

Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003; 98:2663-8. [PMID 14687813]

Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004; 99:844-50. [PMID 15128348]

Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134:459-64. [PMID 11255521]

Savides TJ, Donohue M, Hunt G, Al-Haddad M, Aslanian H, Ben-Menachem T, et al. EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement. Gastrointest Endosc 2007; 66:277-82. [PMID 17643700]

Exact confidence limits for p. Geigy Scientific Tables, 7th Ed. Ciba-Geigy Ltd., Basle: Switzerland, p85-98.

Quantitative Skills. Simple Interactive Statistical Analysis (SISA). Quantitative Skills; Consultancy for Research and Statistics. Hilversum: The Netherlands.

Mansfield SD, Lochan R, Jaques K, Scott J, Bennett MK, O'Sullivan CB, et al. Outcome of patients presenting with suspected pancreato-biliary malignancy. 38th Europoean Pancreatic Club. Volume 6. Tampere, Finland. Pancreatology 2006; 6:358-9.

To'o KJ, Raman SS, Yu NC, Kim YJ, Crawford T, Kadell BM, Lu DS. Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia. Radiographics 2005; 25:949-65. [PMID 16009817]

Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7:1097-103. [PMID 19410017]

Eltoum IA, Chhieng DC, Jhala D, Jhala NC, Crowe DR, Varadarajulu S, Eloubeidi MA. Cumulative sum procedure in evaluation of EUS-guided FNA cytology: the learning curve and diagnostic performance beyond sensitivity and specificity. Cytopathology 2007; 18:143-50. [PMID 17388936]

Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA. Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist's perspective. Am J Clin Pathol 2003; 120:351-67. [PMID 14502798]

Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003; 98:1289-94. [PMID 12818271]

Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010; 71:91-8. [PMID 19846087]

Rosch T, Hofrichter K, Frimberger E, Meining A, Born P, Weigert N, et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 2004; 60:390-6. [PMID 15332029]

Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, et al. Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc 2008; 68:461-6. [PMID 18384788]

Tarantino I, Barresi L, Di Pisa M, Traina M. Simultaneous endoscopic ultrasound fine needle aspiration and endoscopic retrograde cholangio-pancreatography: Evaluation of safety. World J Gastroenterol 2007; 13:3861-3. [PMID 17657842]

Mitsuhashi T, Ghafari S, Chang CY, Gu M. Endoscopic ultrasound-guided fine needle aspiration of the pancreas: cytomorphological evaluation with emphasis on adequacy assessment, diagnostic criteria and contamination from the gastrointestinal tract. Cytopathology 2006; 17:34-41. [PMID 16417563]

Faigel DO, Ginsberg GG, Bentz JS, Gupta PK, Smith DB, Kochman ML. Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 1997; 15:1439-43. [PMID 9193337]

Mergener K, Jowell PS, Branch MS, Baillie J. Pneumoperitoneum complicating ERCP performed immediately after EUS-guided fine needle aspiration. Gastrointest Endosc 1998; 47:541-2. [PMID 9647385]

Di Matteo F, Shimpi L, Gabbrielli A, Martino M, Caricato M, Esposito A, et al. Same-day endoscopic retrograde cholangiopancreatography after transduodenal endoscopic ultrasound-guided needle aspiration: do we need to be cautious? Endoscopy 2006; 38:1149-51. [PMID 17111340]

Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006; 101:139-47. [PMID 16405547]

Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56:652-6. [PMID 12397271]

Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60:721-31. [PMID 15557948]

Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417-23. [PMID 11232684]

Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1-10. [PMID 9684657]

Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54:425-34. [PMID 11577302]

Eloubeidi MA, Gress FG, Savides TJ, Wiersema MJ, Kochman ML, Ahmad NA, et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc 2004; 60:385-9. [PMID 15332028]

Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc 2006; 63:622-9. [PMID 16564863]

Adler DG, Jacobson BC, Davila RE, Hirota WK, Leighton JA, Qureshi WA, et al. ASGE guideline: complications of EUS. Gastrointest Endosc 2005; 61:8-12. [PMID 15672049]

Ramakrishnan S, Crosbie J, Gray H, Panter S, Mansfield SD, Charnley RM, et al. One year prospective audit of ERCP across one Hospital Trust. Gut 2005; 54(Suppl 2):a1-a117.

Fisher L, Fisher A, Thomson A. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 2006; 63:948-55. [PMID 16733108]

Qadeer MA, Vargo JJ, Dumot JA, Lopez R, Trolli PA, Stevens T, et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology 2009; 136:1568-76. [PMID 19422079]

Peter S, Eloubeidi MA. Feasibility of combined EUS-FNA and ERCP for obstructive jaundice from presumed pancreatic malignancy. Nat Clin Pract Gastroenterol Hepatol 2009; 6:132-3. [PMID 19204740]

Freeman Hospital. Newcastle upon Tyne, United Kingdom
Published
2010-11-09
How to Cite
OppongK., RaineD., NayarM., WadehraV., RamakrishnanS., & CharnleyR. (2010). EUS-FNA versus Biliary Brushings and Assessment of Simultaneous Performance in Jaundiced Patients with Suspected Malignant Obstruction. JOP. Journal of the Pancreas, 11(6), 560-567. https://doi.org/10.6092/1590-8577/3398
Section
ORIGINAL ARTICLES